Christopher Larson, MD, PhD

Vice President of Viral Therapy. Sarcoma medical oncologist.
EpicentRx. UCSD.
La Jolla, California, United States

Christopher Larson is a physician-scientist practicing as a sarcoma medical oncologist at UC San Diego and working as scientist at EpicentRx developing the oncolytic virus AdAPT-001. He worked with oncolytic viruses since 2012 during fellowship at UCSD and conducted basic and translational research with AdAPT-001 including development of current manufacturing processes. His clinical practice covers all bone and soft tissue sarcoma types.

Disclosure information not submitted.

Presentation(s):

• Paper 82 - PHASE I/II STUDY OF THE TGF-BETA-TRAP ENHANCED ONCOLYTIC ADENOVIRUS, ADAPT-001, WITH AND WITHOUT AN IMMUNE CHECKPOINT INHIBITOR FOR SARCOMA PATIENTS

  Saturday, November 16, 2024
  10:30 AM – 12:00 PM PST